NCT07704203Not yet recruiting
Preoperative 3D Magnetic Resonance Elastography for Predicting Surgical Risk in Patients Undergoing Hepatectomy
A Prospective Study on Preoperative Regional Liver Function Assessment Using Three-Dimensional Magnetic Resonance Elastography for Predicting Surgical Risk and Postoperative Liver Failure in Patients Undergoing Hepatectomy for Primary or Metastatic Liver Cancer
Source: ClinicalTrials.gov · Last updated 15 Jul 2026
Brief summary (registry, in English)
How to accurately and safely evaluate regional liver function before hepatectomy remains an important unsolved problem in the surgical management of hepatocellular carcinoma (HCC). We plan to develop a non-invasive, functional 3D-MRE-based method for preoperative regional hepatic functional reserve assessment, and to evaluate its ability to predict surgical risk and postoperative liver failure in patients with HCC undergoing hepatectomy.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 150 (estimated)
- First submitted
- 10 Jul 2026
- Start date
- 1 Aug 2026
- Primary completion date
- 1 Oct 2029
- Lead sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Diseases
- Liver and biliary tract cancer
- NCT number
- NCT07704203
What you commit to
- Study type: Observational
- Planned participants: 150
- From 1 Aug 2026 to the primary completion date, 1 Oct 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Contraindication to MRI (e.g., non-MRI-compatible implants, severe claustrophobia)
- Prior history of liver resection or liver transplantation
- Emergency surgery (e.g., due to tumor rupture)
- Severe cardiopulmonary or renal dysfunction precluding surgery
Other
- Child-Pugh class C liver function
- Presence of extrahepatic metastasis
- Pregnant or breastfeeding women
- Unwillingness or inability to comply with study procedures or follow-up
Who the study is looking for
- Age 18-80 years
- Pathologically or radiologically confirmed diagnosis of one of the following: hepatocellular carcinoma, intrahepatic cholangiocarcinoma, or liver metastasis (e.g., from colorectal cancer)
- Scheduled to undergo curative hepatectomy
- Child-Pugh class A or B liver function
- Able to tolerate MRI examination
- Provision of signed and dated informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.